ALNY
Alnylam Pharmaceuticals, Inc. · Healthcare
CEO John Maraganore sold $2.0M of Alnylam Pharmaceuticals, Inc.
Sold$1,950,590
$64.69Price
30,151Shares
−18%Stake
What ALNY did after the filing
- The stock from Tue, Sep 6 open, $69.54
- −45.3%
- S&P 500, same days
- −1.8%
Measured over 30 trading days, to the Oct 18 close.
Traded Tue, Jul 19. Filed Thu, Jul 21, 5:44 PM ET, after the close. Returns use the Sep 6 open and the Oct 18 close. Not investment advice.